Healthcare Innovation PuriCore's focus on developing immunomodulatory drug therapies for inflammatory diseases in dermatology and ophthalmology presents opportunities to collaborate with medical providers and specialty healthcare organizations seeking novel treatment options.

Wound Care Expansion With a proven wound care solution for chronic and acute wounds, PuriCore can target hospitals, clinics, and wound care centers looking to enhance their treatment portfolios with innovative irrigation and wound management products.

Retail Product Diversification Supporting supermarket retail with freshness-enhancing formulations opens avenues to partner with grocery chains, and specialty food retailers interested in extending shelf life and improving product presentation.

Market Positioning As an emerging biotech listed on the London Stock Exchange with growing revenues, PuriCore presents opportunities to attract investors and distribution partners seeking to align with innovative health science and biotechnology solutions.

Growth Potential The company’s focus on small molecule therapies and biopharmaceutical advancements, combined with recent product launches, indicates potential for expansion into new markets and key territories, ideal for sales teams pursuing strategic growth opportunities.